Influence of Lineage-Negative Stem Cell Therapy on Articulatory Functions in ALS Patients

Table 1

Characteristic of the groups with ALS-FRSr and Norris scale results.

Characteristic	Group I ()	Group II ()	Group III ()	value
				I vs. II	I vs. III	II vs. III
Age (, years)				0.021^a	0.97^a	0.89^a
Sex (male/female)	4/2	11/12	1/2	0.72^b	0.81^b	0.89^b
Time from symptom to diagnosis (, months)				0.87^a	0.92^a	0.41^a
Number of Lin^− cells administered ()				0.51^a	0.15^a	0.21^a
ALS-FRSr score ()
Before Lin^− infusion				0.63^c	1.0^c	0.17^c
7 days after Lin^− infusion				0.63^c	1.0^c	0.17^c
28 days after Lin^− infusion				0.58^c	1.0^c	0.28^c
Norris scale score ()
Before Lin^− infusion				1.0^c	0.47^c	0.25^c
7 days after Lin^− infusion				1.0^c	0.77^c	0.19^c
28 days after Lin^− infusion				0.64^c	1.0^c	0.65^c

^aFriedman analysis of variance by ranks for more than two groups. ^bChi-squared test or Yates’ chi-squared test. ^cANOVA Kruskal-Wallis test.